Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)

Status unconfirmed

Conditions studied: COVID-19

In brief

This study is a prospective, single center, observational, cohort study of patients to (1) describe the kinetics and temporal relationship of changes in eicosanoid and cytokine mediators in patients with severe COVID-19 admitted to the hospital; and (2) correlate the dynamic changes in eicosanoid mediators with available patient clinical status, including measures of severity of illness, routine laboratory tests, and outcomes.

Key facts

Study ID

NCT04452942

Run by

EicOsis Human Health Inc.

People needed

30

Starts

2020-07-01

Expected to finish

2021-04-01

Last updated by the study team

2020-07-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Admitted to a hospital with symptoms suggestive of COVID-19.
• Confirmed infection with SARS-CoV-2 as determined by polymerase chain reaction (PCR) or other commercial or public health assay in the 72 hours prior to hospital admission or any time during hospital admission.
• Subject (or legally authorized representative) provides written informed consent prior to initiation of any study procedures.
• Understands and agrees to comply with planned study procedures.
• Agrees to the collection of whole blood samples.

You may not qualify if…

• Inability to obtain informed consent.
• Anticipated transfer to another hospital which is not a study site within 48 hours.
• Inability to obtain sequential blood samples due to patient's characteristics (i.e. difficult vascular access).
• Obstetric patients.
• Prisoners.

Where it is running

• Stony Brook University Hospital — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.